Analysis of Clinical Treatment of Severe Pneumonia Complicated with Diabetes Mellitus

Objective To evaluate the clinical efficacy of severe pneumonia and diabetes with ambroxol adjuvant treatmen.Methods 120 patients of severe pneumonia and diabetes were divided into study group and the control group(60 cases) by a random number table, The control group used of antibiotics and insulin routine treatment, study group with ambroxol on conventional treatment, observed the clinical efficacy of the two groups of patients. Results Lung inflammation control time and hospitalization time of study group were significantly shorter than the control group(P0.05); the cure rate of the study group was 36.67%, significantly higher than the 21.67% of control group(P0.05); the total effective of study group was91.67%, significantly higher than the 66.67% of control group(P0.05); mortality rate of study group was significantly lower than the control group, focus absorption rate was significantly higher(P0.05); there was no significant difference(P0.05)incidence of adverse reactions between the two groups. Conclusion Use ambroxol adjuvant treatment of severe pneumonia and diabetes, can effectively relieve symptoms, lesions accelerate absorption and improve clinical efficacy. It has significant clinical advantages, should be promoted.